rs146051561

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014467.3(SRPX2):​c.1373G>A​(p.Arg458Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,208,481 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 78 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., 31 hem., cov: 22)
Exomes 𝑓: 0.00015 ( 0 hom. 47 hem. )

Consequence

SRPX2
NM_014467.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.893

Publications

3 publications found
Variant links:
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
SRPX2 Gene-Disease associations (from GenCC):
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polymicrogyria, bilateral perisylvian, X-linked
    Inheritance: XL Classification: LIMITED Submitted by: G2P
  • rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked
    Inheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043203235).
BP6
Variant X-100670962-G-A is Benign according to our data. Variant chrX-100670962-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 136 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRPX2NM_014467.3 linkc.1373G>A p.Arg458Gln missense_variant Exon 11 of 11 ENST00000373004.5 NP_055282.1 O60687

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRPX2ENST00000373004.5 linkc.1373G>A p.Arg458Gln missense_variant Exon 11 of 11 1 NM_014467.3 ENSP00000362095.3 O60687
SRPX2ENST00000638920.1 linkn.1376G>A non_coding_transcript_exon_variant Exon 10 of 10 5
SRPX2ENST00000640282.1 linkc.*108G>A 3_prime_UTR_variant Exon 3 of 3 5 ENSP00000491188.1 A0A1W2PNZ6

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
135
AN:
111813
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00403
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000659
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00269
GnomAD2 exomes
AF:
0.000340
AC:
61
AN:
179344
AF XY:
0.000188
show subpopulations
Gnomad AFR exome
AF:
0.00325
Gnomad AMR exome
AF:
0.000554
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000376
Gnomad OTH exome
AF:
0.000224
GnomAD4 exome
AF:
0.000150
AC:
164
AN:
1096615
Hom.:
0
Cov.:
31
AF XY:
0.000130
AC XY:
47
AN XY:
362021
show subpopulations
African (AFR)
AF:
0.00390
AC:
103
AN:
26393
American (AMR)
AF:
0.000485
AC:
17
AN:
35033
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19366
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53723
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40436
Middle Eastern (MID)
AF:
0.000968
AC:
4
AN:
4134
European-Non Finnish (NFE)
AF:
0.0000238
AC:
20
AN:
841298
Other (OTH)
AF:
0.000434
AC:
20
AN:
46056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00122
AC:
136
AN:
111866
Hom.:
0
Cov.:
22
AF XY:
0.000910
AC XY:
31
AN XY:
34060
show subpopulations
African (AFR)
AF:
0.00406
AC:
125
AN:
30822
American (AMR)
AF:
0.000658
AC:
7
AN:
10631
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3534
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2605
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6100
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53119
Other (OTH)
AF:
0.00266
AC:
4
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000516
Hom.:
23
Bravo
AF:
0.00134
ESP6500AA
AF:
0.00495
AC:
19
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000379
AC:
46

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 08, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 05, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Benign:1
Sep 01, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SRPX2-related disorder Benign:1
Jun 07, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.89
T
BayesDel_noAF
Benign
-1.1
CADD
Benign
2.3
DANN
Benign
0.88
DEOGEN2
Benign
0.041
T
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.57
T
M_CAP
Benign
0.0067
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
PhyloP100
0.89
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.29
N
REVEL
Benign
0.016
Sift
Benign
0.51
T
Sift4G
Benign
0.53
T
Polyphen
0.0
B
Vest4
0.089
MVP
0.23
MPC
0.18
ClinPred
0.00079
T
GERP RS
-3.8
Varity_R
0.026
gMVP
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146051561; hg19: chrX-99925959; COSMIC: COSV99342904; COSMIC: COSV99342904; API